Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) EPS (Weighted Average and Diluted) (2022 - 2025)

P3 Health Partners (PIII) has disclosed EPS (Weighted Average and Diluted) for 4 consecutive years, with -$9.67 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) fell 3019.35% year-over-year to -$9.67, compared with a TTM value of $8.91 through Sep 2025, up 157.04%, and an annual FY2024 reading of -$1.08, down 71.43% over the prior year.
  • EPS (Weighted Average and Diluted) was -$9.67 for Q3 2025 at P3 Health Partners, down from -$6.23 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $31.09 in Q4 2024 and bottomed at -$9.67 in Q3 2025.
  • Average EPS (Weighted Average and Diluted) over 4 years is -$0.98, with a median of -$1.27 recorded in 2022.
  • The sharpest move saw EPS (Weighted Average and Diluted) skyrocketed 93.17% in 2023, then plummeted 3472.73% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$2.23 in 2022, then skyrocketed by 94.62% to -$0.12 in 2023, then soared by 26008.33% to $31.09 in 2024, then plummeted by 131.1% to -$9.67 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for PIII at -$9.67 in Q3 2025, -$6.23 in Q2 2025, and -$6.28 in Q1 2025.